Molecular Signal Transduction in Cancer

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cell Signaling".

Deadline for manuscript submissions: 28 February 2027 | Viewed by 99

Special Issue Editors


E-Mail Website
Guest Editor
Deptartment of Biochemistry and Molecular Medicine, School of Medicine and Health Sciences, George Washington University, Washington, DC, USA
Interests: aging; cancer; cell cycle; cell death; cell senescence; cell signaling; oncogenes; tumor suppressors
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Division Pharmacology, Karl Landsteiner University of Health Sciences, Dr.-Karl-Dorrek-Straße 30, 3500 Krems, Austria
Interests: cancer; metastasis; leukemia; AML; JAK-STAT; STAT3
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Dysregulated molecular signal transduction lies at the core of cancer initiation, progression and therapeutic resistance. Genetic and epigenetic alterations disrupt regulatory circuits that normally maintain cell growth and homeostasis, driving the transition to malignancy. As these signaling networks become rewired, they enable tumor cells to override physiological constraints, adapt to metabolic and environmental pressures and remodel their interactions with surrounding stromal and immune cells. This imbalance, arising from disrupted oncogenic and tumor-suppressive signaling, fosters a permissive environment for malignant transformation, disease dissemination and the emergence of treatment-resistant clones.

Our expanding understanding of these altered signaling pathways continues to uncover new mechanistic insights and therapeutic opportunities. Both intrinsic cellular programs and extrinsic cues from the tumor microenvironment shape cancer behavior, and their convergence determines how tumors grow, evolve and respond to therapy. This integrated view of signal transduction has become essential for identifying actionable vulnerabilities, improving biomarker-guided patient stratification and informing rational combination strategies involving targeted agents and immunotherapies.

This Special Issue aims to highlight recent advances in decoding the molecular signaling events that orchestrate tumorigenesis and influence treatment outcomes. We welcome original research, brief reports and review articles that explore canonical and emerging pathways, their biological functions and their translational implications.

Dr. Goberdhan P. Dimri
Dr. Bernhard Zdársky
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • molecular signal transduction
  • tumor microenvironment
  • tumor suppressor
  • kinase signaling
  • transcriptional and epigenetic regulation
  • immune signaling
  • cancer cell communication

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop